Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) shares gapped down before the market opened on Thursday . The stock had previously closed at $9.21, but opened at $7.81. Aveanna Healthcare shares last traded at $8.7190, with a volume of 848,366 shares trading hands.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on the company. JPMorgan Chase & Co. raised Aveanna Healthcare from an “underweight” rating to a “neutral” rating and raised their price target for the company from $6.00 to $10.00 in a report on Thursday, September 18th. UBS Group lifted their target price on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Monday, October 13th. Barclays raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $5.50 to $9.50 in a research note on Tuesday, August 19th. Wall Street Zen upgraded shares of Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 9th. Finally, Raymond James Financial raised Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 target price on the stock in a research note on Monday, August 11th. Three research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $9.29.
Get Our Latest Analysis on AVAH
Aveanna Healthcare Stock Down 2.3%
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last released its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a negative return on equity of 54.56% and a net margin of 0.85%.The company had revenue of $450.53 million for the quarter. On average, research analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current year.
Insider Transactions at Aveanna Healthcare
In other news, major shareholder Paul R. Vigano sold 1,500,000 shares of the business’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $13,500,000.00. Following the transaction, the insider directly owned 362,746 shares of the company’s stock, valued at $3,264,714. The trade was a 80.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 1,251,909 shares of the business’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $9.00, for a total transaction of $11,267,181.00. Following the completion of the transaction, the insider owned 19,292,787 shares of the company’s stock, valued at $173,635,083. This trade represents a 6.09% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 32,597,968 shares of company stock valued at $293,381,712. Corporate insiders own 7.80% of the company’s stock.
Institutional Trading of Aveanna Healthcare
A number of large investors have recently bought and sold shares of AVAH. Banque Transatlantique SA bought a new stake in Aveanna Healthcare during the 1st quarter worth about $25,000. Quantbot Technologies LP acquired a new stake in Aveanna Healthcare in the 2nd quarter worth about $43,000. Jump Financial LLC acquired a new position in Aveanna Healthcare in the 1st quarter valued at $59,000. Diversified Trust Co bought a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $57,000. Finally, MQS Management LLC bought a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at $59,000. 87.96% of the stock is owned by institutional investors.
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Articles
- Five stocks we like better than Aveanna Healthcare
- How to Invest in Biotech Stocks
- Tempus AI: Volatility Equates to Opportunity in AI Leader
- How to Invest in the FAANG Stocks
- Follow the Money: 3 Stocks With High Institutional Ownership
- Buy P&G Now, Before It Sets A New All-Time High
- Can Gold Mining Stocks Shine as the Metals Rally Falters?
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
